Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis

Name: Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis
Creator: Yuanyuan Xu
Published: 2022-12-13T09:22:32.822Z
Keywords: Dermatology

Xu, Yuanyuan; Li, Zhixuan; Wu, Shuwei; Guo, Linghong; Jiang, Xian

doi:10.17632/76czfxgmvb.6

Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis

Published: 13 December 2022| Version 6 | DOI: 10.17632/76czfxgmvb.6

Contributors:

Yuanyuan Xu, Zhixuan Li, Shuwei Wu, Linghong Guo, Xian Jiang

Description

This data is the supplementary data for a manuscript entitled "Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis". In our study, we showed that dupilumab was an effective and safe treatment choice for children and adolescents with AD. More long-term, high-quality, controlled studies in different regions are in demand for further verification.

Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis

Description

Files

Categories

Licence